Tech Stocks emergin...
Health Care: Drugs
Cubist Pharmaceuticals Inc. (CBST: NASDAQ)
$51.13 1.16 | 2.32%
06/18/13 - 04:00 PM ET
746.59K / 846.40K
Vol / Avg. Vol:50.02 / 49.97
Open / Prev. Close:49.82 - 51.13
Today's Range:36.73 - 56.68
52 Wk Range:18.83%
Performance YTD:TheStreet Rating:
Portfolios with CBST
- Portfolio NameUser Type
- ContributorGARP Growers for Summer 2013
- ContributorEarnings Short Squeeze Play...
- ContributorStocks Rising On Unusual Vo...
- ContributorEarnings Short Squeeze Play...
- ContributorEarnings Short Squeeze Play...
- UserGFNN Stockdiagnostics 6
- ContributorStocks At New 52-Week Highs...
- ContributorTop-Rated Biotechnology Stocks
- ContributorEarnings Short Squeeze Play...
- ContributorStocks At New 52-Week Highs...
Latest CBST Headlines from TheStreet
- Cubist Pharmaceuticals Inc. (CBST): Today's Featured Health Care Winner 05.22.13 | 05:05 pm
- Cubist, Optimer, Trius: Antibiotic Deal Making On Tap 05.22.13 | 07:05 am
- Cubist Rises On Unusually High Volume (CBST) 05.21.13 | 12:05 pm
- Analysts' Actions: CBST CNW COH TMHC VFC 05.21.13 | 08:05 am
- 2013 FDA Drug Approval Calendar 05.21.13 | 07:05 am
- Cubist Reaches New 52-Week High (CBST) 05.20.13 | 10:05 am
- 4 GARP Growers to Buy This Summer 05.10.13 | 12:05 pm
- Cramer's Top Stock Picks: PPG ETN CBST NFLX 04.30.13 | 06:04 am
- Cramer's 'Mad Money' Recap: Dazed and Confused Markets 04.29.13 | 08:04 pm
- Cubist Rises On Unusually High Volume (CBST) 04.02.13 | 04:04 pm
Press Releases for CBST
- Cubist Obtains Remaining Rights To Ceftolozane From Astellas - Business Wire 03.11.13 | 08:03 am
- Michael Tomsicek, Cubist CFO (Photo: Business Wire) - Business Wire 03.04.13 | 07:03 am
- FDA Grants QIDP And Fast Track Designations For Cubist’s Late-Stage Antibiotic Candidates - Business Wire 02.28.13 | 04:02 pm
- Cubist Pharmaceuticals To Present At Cowen And Company 33rd Annual Health Care Conference - Business Wire 02.27.13 | 08:02 am
- Cubist Announces Exclusive Option To Acquire Adynxx - Business Wire 02.25.13 | 08:02 am
- Cubist To Present At February Investor Conferences - Business Wire 01.29.13 | 08:01 am
- Cubist Reports Fourth Quarter And Full Year 2012 Financial Results - Business Wire 01.23.13 | 04:01 pm
- Thomas J. DesRosier (Photo: Business Wire) - Business Wire 01.08.13 | 08:01 am
- Cubist Announces Full-Year 2012 Revenues And Provides Business Update - Business Wire 01.07.13 | 07:01 am
- Heptares Partners With Cubist To Research New Medicines Targeting GPCRs - PR Newswire 01.07.13 | 07:01 am
Partner Headlines for CBST
- Encouraging Data on Novartis' Gilenya - Analyst Blog - Zacks 06.14.13 | 10:06 pm
- FDA Accepts Omeros' IND for OMS824 - Analyst Blog - Zacks 05.29.13 | 01:05 am
- NPS Pharma Prices Offering - Analyst Blog - Zacks 05.24.13 | 01:05 am
- UPDATE: Cantor Fitzgerald Upgrades Cubist Pharmaceuticals Following Data on New Drug - Benzinga 05.21.13 | 09:05 am
- Jump On Board With These 2 Companies - Seeking Alpha 04.22.13 | 09:04 am
- Revenues Decline at Alnylam - Analyst Blog - Zacks 11.07.12 | 09:11 am
- Narrower Loss at Optimer - Analyst Blog - Zacks 11.02.12 | 05:11 pm
- Pipeline Progress at Cubist Pharma - Analyst Blog - Zacks 11.01.12 | 06:11 pm
- Stocks Tumble On Disappointing Earnings Reports - Investor's Business Daily 10.19.12 | 04:10 pm
- Stocks Hit Fresh Intraday Lows; Google Reverses Lower - Investor's Business Daily 10.19.12 | 03:10 pm
